en | es | val
en · es · val
Close this search box.

2022 Activity Report

ivo.es 2022 Activity Report

This is the end of a year in which, once again, the staff have proven to be this Institution’s most important asset. Thanks to them, we have been able to face the healthcare crisis we went through, caring for nearly 30,000 cancer patients.

Our activity report means much more than just data. It represents the work capacity, commitment, involvement, and dedication of each and every one of the professionals of this institution, who have put all their efforts into offering quality, personalised, and cutting-edge care service, focusing on the oncology patient and his or her family. 

Since the beginning of its activity as a pioneering specialised oncology centre in Spain, the IVO has consolidated its position as a national and international benchmark for cancer treatment.

We remain faithful to our commitment to the progress of the institution, seeking excellence. So, in 2022, we have made a great effort to improve the technological equipment and our facilities.

In this way, we have completed a cycle of technological renovation that has culminated with the incorporation of the two most advanced linear accelerators in the Valencian Community. The Halcyon model and the VARIAN TrueBeam model are the maximum exponent of state-of the art radiotherapy. A technological bet oriented to successfully address any therapeutic procedure however complicated it may be, and to offer our patients treatments quickly, with maximum precision and safety.

We face 2023 firmly resolved to maintaining the quality standards that set our service to society apart, offering direct and humane treatment to our patients.

The IVO has focused all its efforts on providing quality, personalised, and cutting-edge care service, keeping cancer patients and their families at the heart of our work.

  • The IVO biobank has been the first in Spain to obtain international accreditation ISO20387

    Standard that guarantees the management of the quality of biological material and that accredits the technical competence of all the personnel involved in the activity.

  • The Medical Oncology Service has been reaccredited with the QOPI (Quality Oncology Practice Initiative) certification

    An international reference program that evaluates the quality of cancer care.

  • World’s Best Specialised Hospitals, 2022

    The IVO has once again been acknowledged as one of the World's Best Specialised Hospitals in 2022, an award that places it among the best oncology hospitals in the world.

Manuel Llombart Fuertes
CEO of the IVO Foundation

We face 2023 with the firm intention of maintaining the quality standards that distinguish our service to society, offering direct and humane treatment to our patients.
From these pages, we would like to thank and pay tribute to all those who have made the development and achievements described in this Report possible.